Lean on our expertise across the entire product cycle to navigate your ever-changing industry with confidence, and make insight generation easy.
Craft data-driven commercial strategies that resonate with your diverse stakeholders, from patients and caregivers to providers, payers, hospital stakeholders, and more.
Address the unique challenges you face (including the treatment of patients with rare and ultra-rare diseases) complicated market access and distribution, and more.
Generate healthcare insights that improve patient outcomes, meet provider needs, and assimilate growing regulatory pressures through our evidence-based, innovative research solutions.
Tracking the performance of a revamped messaging campaign required developing a system to measure…
Launching a novel therapy for a rare disease involved building a robust system for continuous…
Benchmarking against competitors required quantitative insights that enabled performance tracking…
Establishing baseline metrics for a new biosimilar involved comprehensive quantitative research to…
Understanding the market landscape and treatment perceptions led to refined positioning strategies…
Refreshing a campaign to better communicate product value involved identifying optimal creative…
Developing a new patient support program required insights into current prescribing processes and…
In-office ethnography, often regarded as the gold standard approach to uncovering the true dynamic…
Trusted and knowledgeable would be two words I’d use to describe KJT. We have a very good strategic relationship – they work with us and not against us.
Having these insights allow us to quickly and confidently make decisions and prioritize opportunities.
KJT is more than just an executor of research – they’re a true strategic partner. We have several continuous ongoing projects with them and they’re always smooth and seamless to work with.
KJT is more than just a vendor, they’re a partner. They always offer a tailored approach and are very responsive.
We have a good and comfortable relationship with KJT. They have a deep understanding of our market. Pricing is fair, and the output is good. You just know what you’re going to get.
A panel discussion that bridges the worlds between insights, advertising, digital solutions, advocacy and more.
Focusing in on the patients with rare diseases, we cover the importance of representing and elevating the patient voice and provide solutions to overcome the unique hurdles of this space. We also discuss the future use of Generative AI, including considerations for ethical and responsible use when aiming to further understand, and communicate to, patients with rare diseases.
Message testing is a crucial process for pharmaceutical and biotech companies when evaluating the…
No matter where you look, generative AI is becoming commonplace. In the realm of healthcare…
In the competitive pharmaceutical and biotech landscapes, the strength of a brand can often be the…
The world of rare diseases and the impact it has on countless lives is often underestimated. Rare…
The unique value of integrating the patient voice into the development process of therapies…
Traditional methods for generating real-world evidence (RWE) from patient-physician conversations…
In pharmaceutical and biotech market research, traditional methodologies to uncover insights from…
Patient-centered research is vital for addressing the information gap in rare disease treatment…
The rise of generative AI has sent ripples through the insights industry. This technology has…
In the rapidly evolving healthcare landscape, the demand for evidence-driven insights has surged to…
